Rejuvenation Technologies Inc. YC 申请

Summer 2018Active

Rejuvenation Technologies Inc. 在 Summer 2018 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2018
行业: HealthcareTherapeutics
团队规模: 2
状态: Active
已发布: 2018

创始人

Glenn MarkovFounder
John RamunasFounder

Rejuvenation Technologies Inc. 做什么

Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.

Rejuvenation Technologies Inc. 的 YC 申请，重建版

Y Combinator 申请

Rejuvenation Technologies Inc.，Summer 2018 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rejuvenation Technologies Inc.

Describe what your company does in 50 characters or less.

mRNA therapeutics to extend healthspan

What is your company going to make? Please describe your product and what it does or will do.

We develop an mRNA drug platform that extends healthspan by reversing telomere shortening. Our therapy extends mouse lifespan by the human equivalent of 10 years with a single dose, showing efficacy in multiple organ systems, including the immune system. We are entering clinical trials to validate this approach in humans, addressing the root cause of aging linked to short telomeres.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA, and plan to base the company here after YC as well.

Explain your decision regarding location.

San Francisco offers the right ecosystem of biotech expertise, funding, and clinical trial access. Being where the science and capital meet is necessary for our clinical-stage gene therapy startup.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Rejuvenation Technologies Inc. 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Rejuvenation Technologies Inc. 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Rejuvenation Technologies Inc. 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Rejuvenation Technologies Inc. 是哪个 YC 批次的？

Rejuvenation Technologies Inc. 是 Y Combinator Summer 2018 批次的成员。

谁创立了 Rejuvenation Technologies Inc.？

Rejuvenation Technologies Inc. 由 Glenn Markov, John Ramunas 创立。

Rejuvenation Technologies Inc. 做什么？

mRNA therapeutics to extend healthspan entering clinical trials

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Rejuvenation Technologies Inc. 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。